Zhengye Biotechnology Holding (ZYBT) Invested Capital (2023 - 2025)
Zhengye Biotechnology Holding (ZYBT) posted quarterly Invested Capital of $9.2 million for Q4 2025, down 11.43% year-over-year from $10.4 million in Q4 2024, and up 33095.07% quarter-over-quarter from $27650.5 in Q2 2025.
Zhengye Biotechnology Holding (ZYBT) Invested Capital (2023 - 2025) Analysis & Trends
Zhengye Biotechnology Holding (ZYBT) has reported Invested Capital for 3 consecutive years, with $9.2 million the latest figure, recorded in Q4 2025.
- In Q4 2025, Invested Capital fell 11.43% year-over-year to $9.2 million; the TTM figure through Dec 2025 stood at $30.7 million (changed N/A YoY), while the FY2025 annual figure was $9.2 million, down 10.0% from the prior year.
- Invested Capital rose to $9.2 million in Q4 2025 per ZYBT's latest filing, from $27650.5 in the prior quarter.
- Across five years, Invested Capital topped out at $11.1 million in Q4 2023 and bottomed at $27650.5 in Q2 2025.
- Historically, Invested Capital has averaged $7.7 million across 3 years, with a median of $9.8 million in 2024.
- Annual changes were most pronounced in 2024 — Invested Capital decreased 6.56% — and 2025, when it fell 11.43%.
- Zhengye Biotechnology Holding's Invested Capital stood at $11.1 million in 2023, then retreated by 6.56% to $10.4 million in 2024, then fell by 11.43% to $9.2 million in 2025.
- Business Quant data shows ZYBT's Invested Capital at $9.2 million in Q4 2025, $27650.5 in Q2 2025, and $10.4 million in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Invested Cap. (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.91 Bn | 42.95 Bn | - | 9.90 Bn |
| 2 | Teva Pharmaceutical Industries | 43.15 Bn | 39.49 Bn | 2.15 Bn | 4.50 Bn |
| 3 | Zoetis | 31.52 Bn | 29.84 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.58 Bn | 22.78 Bn | 5.10 Bn | 3.74 Bn |
| 5 | United Therapeutics | 22.16 Bn | 19.50 Bn | 683.80 Mn | - |
| 6 | Viatris | 18.76 Bn | 17.87 Bn | 1.46 Bn | 1.74 Bn |
| 7 | Neurocrine Biosciences | 15.48 Bn | 15.09 Bn | 935.80 Mn | - |
| 8 | Elanco Animal Health | 11.69 Bn | 11.16 Bn | 798.00 Mn | 73.00 Mn |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.96 Bn | - | 630.00 Mn |
| 10 | Zhengye Biotechnology Holding | 88.07 Mn | 80.75 Mn | - | 9.18 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 9.18 Mn |
| Jun 30, 2025 | 27,650.55 |
| Dec 31, 2024 | 10.36 Mn |
| Dec 31, 2023 | 11.09 Mn |